By addressing its solubility constraints and highlighting its potential in tauopathy-related applications, we have contributed to the understanding of BT1 as a valuable tool for further research in the field of tau monitoring in neurodegenerative diseases. This evidence concerns the gene MAPT and neurodegenerative disease.